Arş. Gör. İstemi SERİN

Yayın Ağı

Makaleler 11

1. Isotretinoin-induced phenotypic shift from severe asthma to eosinophilic granulomatosis with polyangiitis

Bektas E., Yilmaz A., Kilic M. F., Serin I., Bes C.

Rheumatology , cilt.65, sa.5, 2026 (SCI-Expanded, Scopus)

2. The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma

Serin I., Oyaci Y., PEHLİVAN S., Ertas E., Tuncel F. C., Pehlivan M.

Discover Oncology , cilt.16, sa.1, 2025 (SCI-Expanded, Scopus)

3. The role of immune checkpoint inhibitors: Variable number of tandem repeat (VNTR) polymorphism in the second exon of the P-selectin glycoprotein ligand-1 (PSGL-1) gene polymorphism in multiple myeloma

Oyaci Y., Pehlivan M., PEHLİVAN S., Cinli T. A., Tuncel F. C., Ertas E., et al.

Molecular Carcinogenesis , cilt.63, sa.10, ss.1980-1987, 2024 (SCI-Expanded, Scopus)

4. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?

Goze H., Cinli T. A., Baydilli K. N., Serin I.

International Journal of Hematology-Oncology and Stem Cell Research , cilt.18, sa.1, ss.14-32, 2024 (Scopus)

5. Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

Eren R., Serin I., Atak S., PİRDAL B. Z., Nizam N., Gemici A., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.39, sa.2, ss.191-199, 2023 (SCI-Expanded)

6. Inherited transmission of the CSF3R T618I mutation: a familial report

Serin I., Cinli T. A., Tunc S., Kaynar L., Sevindik O. G., Yokus O.

ANNALS OF HEMATOLOGY , cilt.102, sa.2, ss.477-479, 2023 (SCI-Expanded, Scopus)

7. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., Dal M. S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded)

8. What are the roles of global DNA and APC 2 gene promotor hypermethylation in multiple myeloma?

Pehlivan S., Serin I., NURSAL A. F., Oyaci Y., GÜNDEŞ İ., Pehlivan M.

MOLECULAR BIOLOGY REPORTS , cilt.48, sa.12, ss.7875-7882, 2021 (SCI-Expanded, Scopus)

9. Effect of the uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1) genes on treatment efficacy and survival in patients with multiple myeloma: a single-center study

Demir I., Pehlivan S., Okan V., ŞAHİN H. H., Durusoy S. S., Serin I., et al.

BMC RESEARCH NOTES , cilt.14, sa.1, 2021 (ESCI, Scopus)

10. **A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism**

Serin I., Pehlivan S., GÜNDEŞ İ., Fidan Oyaci Y., PEHLİVAN M.

ANNALS OF HEMATOLOGY , cilt.100, sa.2, ss.421-427, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. The Negative Effects of Inula Viscosa L. Use on a Cancer Treatment

BAVUNOĞLU I., TÜRKMEN Z., SERİN İ., KULOĞLU M., TEKİN T., MERCAN S., et al.

ACTA SCIENTIFIC MEDICAL SCIENCES , cilt.2, sa.8, ss.19-24, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

Sevindik O., BİLGEN H., Serin I., MELEK E., Karaku V., Cerci K., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, Amerika Birleşik Devletleri, 10 - 13 Aralık 2022, ss.12803-12804

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler